ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1792 • 2014 ACR/ARHP Annual Meeting

    Clinical-Biological and Pathological Spectrum and Outcome of IgA Vasculitis in Adults: A French Study

    Alexandra Audemard1, Evangeline Pillebout2, Patrice Cacoub3, Noémie Jourde-Chiche Sr.4, Zahir Amoura5, Noemie Le Gouellec6, Francois Maurier7, Boris Bienvenu8, Geoffrey Urbanski9, Sébastien Sanges10, Aurélie Hummel11, Alban Deroux12, Loic Raffray13, Luc Mouthon14, Loïc Guillevin for the French Vasculitis Study Group14, Eric Thervet15 and Benjamin Terrier16, 1Internal Medicine, Centre Hospitalier Universitaire de Caen, Caen, France, 2Nephrology, Saint Louis, Paris, France, 3Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France, 4Nephrology, CHU, Marseille, France, 5Internal medicine 2, French National Reference Center for Systemic Lupus and Antiphospholipid Syndrome, Pitié-Salpêtrière Hospital (AP-HP), Paris, France, 6Internal Medicine, Lille, France, 7HP Metz Belle Isle Hospital, Department of Internal Medicine, Metz, France, 8Médecine interne, CHU Côte de Nacre, CAEN, France, 9Internal Medicine, CHRU, Lille, France, 10Service de médecine interne, Centre National de Référence de la Sclérodermie Systémique, Hôpital Claude Huriez, CHRU Lille, Lille, France, 11Nephrology, Necker Hospital, Paris, France, 12Internal Medicine, CHU Grenoble, Grenoble, France, 13INTERNAL MEDICINE, bordeaux, France, 14National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 15Nephrology, Hopital Européen Georges Pompidou, APHP, PARIS, France, 16National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France

    Background/Purpose IgA vasculitis is an immune-complex small-vessel vasculitis that mainly affects children and, more rarely, adults, in whom it seems to be more severe, because…
  • Abstract Number: 1804 • 2014 ACR/ARHP Annual Meeting

    Increased Mortality in Ankylosing Spondylitis – Results from a National Population Based Study

    Sofia Exarchou1, Elisabeth Lie2, Johan Askling3, Helena Forsblad-d'Elia2, Carl Turesson1, Lars Erik Kristensen4 and Lennart T. Jacobsson2, 1Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 3Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, 4Section of Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden

    Background/Purpose: Ankylosing spondylitis (AS) is characterized both by inflammation of the axial skeleton and systemic inflammation, and may also involve joints, entheses and other organs.…
  • Abstract Number: 1800 • 2014 ACR/ARHP Annual Meeting

    Objectively Measured Sedentary Behavior Is a Distinct Risk Factor from Low Moderate-to-Vigorous Activity in Predicting Subsequent Frailty: Evidence from Osteoarthritis Initiative

    Jing Song1, Lee A. Lindquist1, Rowland W. Chang1, Pamela A. Semanik2, Linda S. Ehrlich-Jones3, Jungwha Lee4, Min-Woong Sohn1 and Dorothy D. Dunlop1, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Rush University Medical Center, Chicago, IL, 3Rehabilitation Institute of Chicago, Chicago, IL, 4Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Physical frailty represents a state of high vulnerability for adverse health outcomes including disability and mortality. Physical activity interventions to improve health have largely…
  • Abstract Number: 1777 • 2014 ACR/ARHP Annual Meeting

    Staphylococcus Aureus Nasal Carriage and Relapses, Bvas, ANCA-Positivity and Cotrimoxazole Use in ANCA-Associated Vasculitis

    Boun Kim Tan1, Yoann Crabol1, Jason Tasse2,3, Frederic Laurent2,3, Xavier Puechal4,5, Christine Vinter6 and Loïc Guillevin1,5, 1Internal Medicine, Hôpital Cochin, University Paris V Descartes, Paris, France, 2Laboratoire de Bactériologie de l'hôpital de la Croix-Rousse, National Reference Centre for Staphylococci, Lyon, France, 3INSERM U1111, CNRS UMR5308, International Centre for Research in Infectious Diseases, Lyon, France, 4Internal Medicine, Hôpital Cochin, Paris, France, 5French Vasculitis Study Group (FVSG), Paris, France, 6Internal Medecine, Hôpital Cochin, Paris, France

    Background/Purpose Staphylococcus aureus (SA) nasal carriage has been reported to be more frequent and associated with persistent ANCA-positivity and relapse in patients with granulomatosis with…
  • Abstract Number: 1776 • 2014 ACR/ARHP Annual Meeting

    Factors Predictive of ANCA-Associated Vasculitis Relapse in Patients Given Rituximab-Maintenance Therapy

    Benjamin Terrier1, Christian Pagnoux2, Guillaume Geri3, Alexandre Karras4, Chahéra Khouatra5, Olivier Aumaitre6, Pascal Cohen7, Francois Maurier8, Olivier Decaux9, Hélène Desmurs-Clavel10, Pierre Gobert11, Thomas Quemeneur12, Claire Blanchard-Delaunay13, Pascal Godmer14, Xavier Puéchal7, Luc Mouthon7 and Loïc Guillevin for the French Vasculitis Study Group7, 1National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 2Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 3Intensive Care Unit, Cochin Hospital, Paris, France, 4Nephrology, Hôpital Européen Georges Pompidou, APHP, Paris, France, 5CHU Louis Pradel, Lyon, Lyon, France, 6Internal Medicine, CHU, Clermont-Ferrand, France, 7National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 8HP Metz Belle Isle Hospital, Department of Internal Medicine, Metz, France, 9Department of Internal Medicine, Rennes University Hospital, Rennes, France, 10University of Lyon, LYON, France, 11Nephrology, Centre Hospitalier d'Avignon, Avignon, France, 12Internal Medicine, CH, Valenciennes, France, 13Internal Medicine, Hôpital de Niort, Niort, France, 14Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique de Vannes, Vannes, France

    Background/Purpose Rituximab (RTX) was shown to be as effective as cyclophosphamide to induce remission in patients with ANCA-associated vasculitis (AAV). The prospective MAINRITSAN trial compared…
  • Abstract Number: 1775 • 2014 ACR/ARHP Annual Meeting

    Predicting Relapse in Patients with Granulomatosis with Polyangiitis – the Potential Use of Monitoring in Vitro ANCA Production

    Judith Land1, Wayel H. Abdulahad1, Coen A. Stegeman2, Peter Heeringa3 and Abraham Rutgers1, 1Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 2Nephrology, University Medical Center Groningen, Groningen, Netherlands, 3Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose Patients with granulomatosis with polyangiitis (GPA) suffer from frequent disease relapses, with up to 50% of patients relapsing within 5 years. Several risk factors…
  • Abstract Number: 1774 • 2014 ACR/ARHP Annual Meeting

    Granulomatosis with Polyangiitis (Wegener’s): Endoscopic Management of Tracheobronchial Stenosis – Results from a Multicenter Experience in 47 Patients

    Benjamin Terrier1, Agnes Dechartres2, Charlotte Girard3, Stéphane Jouneau4, Jean-Emmanuel Kahn5, Robin Dhote6, Jean Cabane7, Estibaliz Lazaro8, Thomas Papo9, Nicolas Schleinitz10, Guillaume Le Guenno11, Luc Mouthon12 and Loïc Guillevin for the French Vasculitis Study Group12, 1National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 2Biostatistics, Hotel Dieu, Paris, France, 3Internal Medicine, CHU, Lyon, France, 4Pulmonology, CHU, Rennes, France, 5Internal Medicine, Foch Hospital, Suresnes, France, 6Internal Medicine, Avicenne University Hospital, Bobigny, France, 7Internal Medicine, Saint-Antoine, Paris, France, 8Centre François Magendie, CHU, Pessac, France, 9Internal Medicine, Bichat Hospital, Paris, Paris, France, 10internal medicine, APHM, marseille, France, 11Internal Medicine department, Clermont-Ferrand, France, 12National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France

    Background/Purpose Tracheobronchial stenosis (TBS) is noted in 12 to 23% in patients with granulomatosis with polyangiitis (GPA), and includes subglottic stenosis (SGS) and bronchial stenosis.…
  • Abstract Number: 1773 • 2014 ACR/ARHP Annual Meeting

    Otolaryngologic Lesions Are Not Rare and Closely Related with Pachymeningitis and Cranial Neuropathy in MPO-ANCA Associated Vasculitis

    Takahiro Nunokawa1, Naoto Yokogawa2, Kota Shimada1 and Shoji Sugii2, 1Department of Rheumatic diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, 2Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

    Background/Purpose: Recently several case reports of serous otitis media (SOM), hypertrophic pachymeningitis (HP) and cranial neuropathy (CN) have been reported in connection with MPO-ANCA associated…
  • Abstract Number: 1772 • 2014 ACR/ARHP Annual Meeting

    Venous Thromboembolic Events in Eosinophilic Granulomatosis with Polyangiitis (EGPA)

    Chiara Baldini1, Francesco Ferro1, Nicoletta Luciano1, Antonio Tavoni2, Francesca Sernissi1, Daniela Martini1, Sara L'Abbate1, Marta Mosca3 and Stefano Bombardieri3, 1University of Pisa, Rheumatology Unit, Pisa, Italy, 2University of Pisa, Immunoallergology Unit, Pisa, Italy, 3Rheumatology Unit, University of Pisa, Pisa, Italy

    Background/Purpose: Previous studies have documented an increased risk of venous thromboembolic events in patients with antineutrophil cytoplasmic antibodies (ANCA) associated vasculitides (AAV) as compared to…
  • Abstract Number: 1771 • 2014 ACR/ARHP Annual Meeting

    Arterial Thrombotic Events in Systemic Vasculitis

    Alexander Tsoukas1, Sasha Bernatsky2, Lawrence Joseph3, David Buckeridge4, Patrick Belisle5 and Christian A. Pineau1, 1Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 2Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 3McGill University, Montreal, QC, Canada, 4Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada, 5Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose To estimate the incidence rate of clinically apparent arterial thrombotic events and associated comorbidities in patients with primary systemic vasculitis. Methods Using large-cohort administrative…
  • Abstract Number: 1770 • 2014 ACR/ARHP Annual Meeting

    Increased Risk of Chronic Obstructive Pulmonary Disease in Granulomatosis with Polyangiitis: A General Population-Based Study

    Neda Amiri1, Mohsen Sadatsafavi2, Eric C. Sayre3, John M. Esdaile4 and J. Antonio Avina-Zubieta2,5, 1Rheumatology, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, 5Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada

    Background/Purpose             Chronic obstructive pulmonary disease (COPD) is increasingly recognized as an inflammatory condition. We aimed to identify the risk of newly recorded COPD among…
  • Abstract Number: 1769 • 2014 ACR/ARHP Annual Meeting

    Abdominal Visceral Adipose Tissue Measured By DXA As a Novel Surrogate Marker of Cardiovascular Risk in Primary Necrotizing Vasculitides

    Bertrand Dunogué1, Karine Briot2, Sami Kolta3, Alexis Regent4, Pascal Cohen5, Alice Berezne6, Xavier Puéchal5, Claire Le Jeunne5, Luc Mouthon5, Christian Roux7, Loïc Guillevin for the French Vasculitis Study Group5 and Benjamin Terrier8, 1Internal Medicine, Hôpital Cochin, Paris, France, 2Cochin Hospital, Paris Descartes University, Paris, France, 3Rheumatology B, Paris Descartes University, Cochin hospital, Paris, France, 4Internal Medicine, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université Paris Descartes, Paris, France, Paris, France, 5National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 6Paris Descartes University, Internal Medicine department, Cochin Hospital, Paris, France, 7Paris Descartes University, Cochin Hospital, Paris, France, 8National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France

    Background/Purpose Studies have shown a strong prevalence of cardiovascular events among patients with primary necrotizing vasculitides. Recent studies indicate that visceral adipose tissue (VAT) is…
  • Abstract Number: 1768 • 2014 ACR/ARHP Annual Meeting

    Cardiac Involvement in Granulomatosis with Polyangiitis: A Magnetic Resonance Imaging Study of 31 Consecutive Patients

    Grégory Pugnet1,2, Xavier Puéchal1, Benjamin Terrier1, Hervé Gouya3, Andre Kahan4, Paul Legmann3, Loïc Guillevin1 and Olivier Vignaux5, 1National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 2Toulouse University Hospital, Internal Medicine Department, Toulouse, France, 3AP-HP Cochin Hospital, Department of Radiology B, Paris, France, 4Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France, 5Radiology, Cochin University Hospital, Paris, France

    Background/Purpose Cardiac manifestations in granulomatosis with polyangiitis (GPA) patients are usually considered to be rare but may be life-threatening.  However specific cardiac involvement in GPA is…
  • Abstract Number: 1767 • 2014 ACR/ARHP Annual Meeting

    Granulomatosis with Polyangiitis (Wegener’s) According to Geographic Origin and Ethnicity: Clinical-Biological Presentation and Outcome

    Benjamin Terrier1, Christophe Deligny2, Xavier Puéchal3, Pascal Godmer4, Pierre Charles5, Gilles Hayem6, Bertrand Dunogué7, Pascal Cohen3, Serge Arfi8, Luc Mouthon3 and Loïc Guillevin for the French Vasculitis Study Group3, 1National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 2Internal Medicine, CHU Fort de France, Fort de France, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 4Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique de Vannes, Vannes, France, 5Internal Medicine, Institut Mutualiste Montsouris, Paris, France, 6Rhumatologie, Hopital Bichat, Paris Cedex 18, France, 7Internal Medicine, Hôpital Cochin, Paris, France, 8Rhumatologie Et Médecine Interne, Centre hospitalier Universitaire de Fort de France, Fort de France, Martinique

    Background/Purpose Granulomatosis with polyangiitis (Wegener’s) (GPA) is an ANCA-associated vasculitis (AAV) predominantly affecting small-sized vessels, involving mainly the upper and lower respiratory tracts and kidneys.…
  • Abstract Number: 1766 • 2014 ACR/ARHP Annual Meeting

    Comparison of Clinicopathologically- and Serologically-Based Classification Systems for ANCA-Associated Vasculitis

    Sebastian Unizony1, Eli M. Miloslavsky1, Miguel Villarreal2, Peter A. Merkel3, Paul Monach4, E. William St. Claire5, Cees Kallenberg6, David Ikle2, Robert F. Spiera7, Nadia Tchao8, Deborah J. Phippard8, Linna Ding9, Carol A. Langford10, Philip Seo11, Gary S. Hoffman12, John H. Stone1 and Ulrich Specks13, 1Rheumatology, Massachusetts General Hospital, Boston, MA, 2Rho, Chapel Hill, NC, 3University of Pennsylvania, Philadelphia, PA, 4Rheumatology, Boston University, Boston, MA, 5Rheumatology, Duke University School of Medicine, Durham, NC, 6Rheumatology and Clinical Immunology, University of Groningen, Groningen, Netherlands, 7Rheumatology, Hospital for Special Surgery, New York, NY, 8Immune Tolerance Network, Bethesda, MD, 9NIAID, Bethesda, MD, 10Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, 11Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, 12Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, 13Frederichs Dr NW, Mayo Clinic, Rochester, MN

    Background/Purpose Genome-wide association studies suggest that PR3-ANCA-positive ANCA-associated vasculitis (AAV) is genetically distinct from MPO-ANCA AAV.  We evaluated patients enrolled in the RAVE trial according…
  • « Previous Page
  • 1
  • …
  • 1931
  • 1932
  • 1933
  • 1934
  • 1935
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology